scispace - formally typeset
E

Elisabet Jerlhag

Researcher at University of Gothenburg

Publications -  87
Citations -  4474

Elisabet Jerlhag is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Ghrelin & Nucleus accumbens. The author has an hindex of 31, co-authored 76 publications receiving 3741 citations.

Papers
More filters
Journal ArticleDOI

Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens.

TL;DR: Findings indicate that ghrelin might, via activation of GHSR‐1A in the VTA and LDTg, stimulate the acetylcholine–dopamine reward link, implicating that gh Relin is a part of the neurochemical overlap between the reward systems and those that regulate energy balance.
Journal ArticleDOI

Requirement of central ghrelin signaling for alcohol reward

TL;DR: Central ghrelin signaling, via GHS-R1A, not only stimulates the reward system, but is also required for stimulation of that system by alcohol.
Journal ArticleDOI

Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward.

TL;DR: Ghrelin may, via activation of the acetylcholine–dopamine reward link, increase the incentive values of signals associated with motivated behaviours of importance for survival such as feeding behaviour, and whether this has therapeutic implications for compulsive addictive behaviours.
Journal ArticleDOI

Ghrelin Increases Intake of Rewarding Food in Rodents

TL;DR: This article investigated whether ghrelin action at the level of the ventral tegmental area (VTA), a key node in the mesolimbic reward system, is important for the rewarding and motivational aspects of the consumption of rewarding/palatable food.
Journal ArticleDOI

The role of the central ghrelin system in reward from food and chemical drugs

TL;DR: The central ghrelin signalling system interfaces neurobiological circuits involved in reward from food as well as chemical drugs; agents that directly or indirectly suppress this system emerge as potential candidate drugs for suppressing problematic over-eating that leads to obesity as wellAs for the treatment of substance use disorder.